The Quest for a Vaccine Against Coccidioidomycosis: A Neglected Disease of the Americas
Open Access
- 16 December 2016
- journal article
- review article
- Published by MDPI AG in Journal of Fungi
- Vol. 2 (4), 34
- https://doi.org/10.3390/jof2040034
Abstract
Coccidioidomycosis (Valley Fever) is a disease caused by inhalation of Coccidioides spp. This neglected disease has substantial public health impact despite its geographic restriction to desert areas of the southwestern U.S., Mexico, Central and South America. The incidence of this infection in California and Arizona has been increasing over the past fifteen years. Several large cities are within the endemic region in the U.S. Coccidioidomycosis accounts for 25,000 hospital admissions per year in California. While most cases of coccidioidomycosis resolve spontaneously, up to 40% are severe enough to require anti-fungal treatment, and a significant number disseminate beyond the lungs. Disseminated infection involving the meninges is fatal without appropriate treatment. Infection with Coccidioides spp. is protective against a second infection, so vaccination seems biologically plausible. This review of efforts to develop a vaccine against coccidioidomycosis focuses on vaccine approaches and the difficulties in identifying protein antigen/adjuvant combinations that protect in experimental mouse models. Although the quest for a vaccine is still in the early stage, scientific efforts for vaccine development may pave the way for future success.Keywords
This publication has 57 references indexed in Scilit:
- Gene expression in human fungal pathogen Coccidioides immitis changes as arthroconidia differentiate into spherules and matureBMC Microbiology, 2013
- Construction and Evaluation of a Novel Recombinant T Cell Epitope-Based Vaccine against CoccidioidomycosisInfection and Immunity, 2012
- Comparative Transcriptomics of the Saprobic and Parasitic Growth Phases in Coccidioides sppPLOS ONE, 2012
- Nitric oxide synthase activity has limited influence on the control of Coccidioides infection in miceMicrobial Pathogenesis, 2011
- The role of reactive oxygen intermediates in experimental coccidioidomycois in miceBMC Microbiology, 2011
- Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in miceJCI Insight, 2011
- Comparative genomic analyses of the human fungal pathogens Coccidioides and their relativesGenome Research, 2009
- A Genetically Engineered Live Attenuated Vaccine ofCoccidioides posadasiiProtects BALB/c Mice against CoccidioidomycosisInfection and Immunity, 2009
- Multivalent Recombinant Protein Vaccine against CoccidioidomycosisInfection and Immunity, 2006
- Coccidioidomycosis—A Fungal Disease of the AmericasPLoS Medicine, 2005